July 10, 2023
JMMB Group Limited (JMMBGL) for the year ended March 31, 2023, recorded net interest income of $11.18 billion, a 5% decrease when compared with $11.80 billion recorded for the corresponding period in 2022. Interest income for the year amounted to $36.06 billion compared to $27.36 billion reported in 2022. Interest expenses increased 60% to total $24.89 billion relative to the $15.56 billion recorded for the same period in 2022. Net interest income for the quarter amounted to $2.74 billion, a 3% decrease when compared with the $2.82 billion recorded for the same period in 2022.
Fees earned from managing funds on behalf of clients amounted to $2.08 billion versus $2.03 billion recorded the prior year. Gains on securities trading declined 52% to $3.51 billion (2022: $7.32 billion).
Foreign exchange margins from Cambio trading rose 26%, totalling $3.25 billion (2022: $2.59 billion), While net loss from financial assets at fair value through profit or loss (FVTPL) closed at $400.36 million relative to net income of $58.48 million at the end of the 2022FY.
Operating revenue net of interest expenses amounted to $23.38 billion (2022: $26.55 billion), a decline of 12% year over year. This is also inclusive of 36% increase in dividend income, closing at $193.03 million (2022: $141.89 million). Total other income amounted to $112.09 million from $26 million booked at the end of 2022FY, reflecting a 331% jump.
Staff costs marginally increased to $10.47 billion from $10.34 billion booked at the end of 2022FY, while other expenses were up 16% to $9.45 billion (2022: $8.17 billion).
As a result, operating profit amounted to $3.58 billion, down 56% when compared to the $8.07 billion reported in 2022.
Impairment loss on financial assets decreased from $1.93 billion in 2022FY to $1.56 billion at the end of the 2023FY.
Gain on disposal of property plant and equipment increased 63% to close at $7.56 million versus 2022FY gain of $4.63 million.
Share of Profit of associated company amounted to $2.67 billion (2022: $5.08 billion). As such, JMMBGL recorded a profit before taxation of $4.63 billion, a 59% decrease over the $11.22 billion recorded for the corresponding period in 2021. As for the quarter, there was a loss before taxation totalling $332.07 million (2022: Profit of $1.15 billion). Tax credit for the period amounted to $1.65 billion, a huge 333% increase relative to a tax credit of $379.95 million recorded in 2022.
Consequently, JMMBGL booked a 46% decrease in net profit for the year to close $6.28 billion compared to $11.60 billion reported for 2022. Net profit for the quarter amounted to $1.51 billion, relative to the $2.77 billion reported for the same quarter of 2022.
Net profit attributable to the shareholders of the company totalled $6.17 billion relative to $11.02 billion in 2022, a 44% decline year over year. Additionally, JMMBGL posted total comprehensive loss of $872.22 million compared to a loss of $3.65 billion in 2022.
As a result, earnings per share (EPS) for the financial year amounted to $3.15 (2022: $5.64), while EPS for the quarter amounted to $0.84 (2022: $1.40). The number of shares used in the calculations amounted to 1,955,552,532 units. Notably, JMMBGL’s stock price closed trading on July 10, 2023, at $29.20 at corresponding P/E at 9.26 times.
Balance Sheet at a glance:
Total assets as at March 31, 2023 amounted to $665.35 billion relative to $613.29 billion in 2022. The movement was due to an increase in ‘Investment securities’ to close at $342.48 billion (2022: $332.08 billion) and growth in ‘Loans and notes receivables’ which closed at $177.98 billion (2022: $141.90 billion). ‘Interest in associated companies’ also contributed to the increase in the asset base closing at $40.38 billion (2022: $42.78 billion).
Shareholders ‘equity totalled $53.33 billion (2022: $54.12 billion). As a result, book value per share stood at $27.27 (2022: $27.68).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.